Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $2.15 to $1.4.
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $2.15 to $1.4.